跳至主要内容
临床试验/TCTR20201218001
TCTR20201218001已完成4 期

Efficacy of Topical Ethyl Chloride Spray versus Subcutaneous 1% Lidocaine Injection in Reducing Pain from Two Rods System Implant Insertion

one0 个研究点目标入组 110 人开始时间: 2020年12月18日最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
发起方
one
入组人数
110

研究概览

简要总结

All basic clinical characteristics between the two groups showed no significant difference. Mean VAS during anesthetic in the Ethyl Chloride Spray (ECS) group were significantly lower than in the Lidocaine injection (LI) group (3.92 and 2.89, p 0.01). However, the mean VAS during; (1) implant insertion, (2) 20 min after implant insertion and (3) overall pain, in the ECS group were significantly higher than in the LI group (4.83, 1.61, 3.11 versus 0.98, 0.09, p 0.01)

研究设计

研究类型
Interventional

入排标准

年龄范围
18 Years 至 40 Years(—)
性别
Female

入选标准

  • 1.Thai literate women over 18 Years with parental or caregiver permission who prefer to use two rods system contraceptive implant.
  • 2.No contraindication for one rod system implant.

排除标准

  • 1.Known allergic to either analgesic methods.
  • 2.Removal and reinsertion of subdermal implant at the same time.
  • 3.Received pain killer within 4 hours prior to the procedur.

研究者

发起方
one

相似试验